NCT01129401

Brief Summary

This treatment outcome evaluation of the Stonewall Project will recruit 150 participants to complete a face-to-face assessment visit at baseline, 3-month follow-up, and 6-month follow-up to examine treatment outcome with respect to HIV risk and substance use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Mar 2010

Longer than P75 for phase_1

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2010

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 24, 2010

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

October 27, 2014

Status Verified

October 1, 2014

Enrollment Period

2.8 years

First QC Date

May 6, 2010

Last Update Submit

October 23, 2014

Conditions

Keywords

methamphetaminemen who have sex with menHIV/AIDS

Outcome Measures

Primary Outcomes (1)

  • stimulant use (measured via self-report and urine toxicology screening)

    Participants will complete a self-report measure that assesses substance use during the past month. We will examine the total number of days that stimulants (cocaine, crack, or methamphetamine) were used during the past month. We will also conduct urine toxicology screening to determine whether participants test positive for cocaine or methamphetamine metabolites at each study visit. This is an objective measure of recent stimulant use (i.e., during the past 72 hours).

    3 and 6 month follow-ups

Secondary Outcomes (1)

  • sexual risk taking

    3 and 6 month follow-ups

Study Arms (1)

Stonewall Project Participants

OTHER
Behavioral: Stonewall Project

Interventions

The Stonewall Project is an outpatient substance abuse treatment program for methamphetamine-using MSM that includes individual counseling, group counseling, and visits with a psychiatrists where indicated.

Stonewall Project Participants

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Participants in the outcome evaluation must have initiated services at the Stonewall Project within the past 60 days.

You may not qualify if:

  • \- Inability to provide informed consent as judged by the Co-PI's and study team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

San Francisco AIDS Foundation

San Francisco, California, 94103, United States

Location

University of California, San Francisco

San Francisco, California, 94105, United States

Location

Related Links

MeSH Terms

Conditions

Substance-Related DisordersHIV InfectionsHomosexualityAcquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSexualitySexual BehaviorBehaviorSlow Virus Diseases

Study Officials

  • Adam W Carrico, Ph.D.

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • William J Woods, Ph.D.

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Michael D. Siever, Ph.D.

    San Francisco AIDS Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2010

First Posted

May 24, 2010

Study Start

March 1, 2010

Primary Completion

December 1, 2012

Study Completion

May 1, 2014

Last Updated

October 27, 2014

Record last verified: 2014-10

Locations